If you're interested in getting a health technology evaluated by NICE you should register the product with the NHS Innovation Service. We review those technologies submitted to the Innovation Service on a regular basis. A submission will ensure that a technology is considered in the round, when we're identifying topics for appraisal/guidance.

Should the technology, once submitted, map over to a relevant priority area in the future, we will contact you as a stakeholder in the process.

How we select technologies

A technology can only be selected if it meets the eligibility criteria and:

  • it offers substantial benefits to patients or the health and care system compared with current practice

  • the benefits are plausible, clearly described, easily understood and supported by evidence

  • developing guidance would mean faster and more consistent adoption of the technology.

Eligibility criteria

  1. The technology must be suitable for development under one of our guidance programmes, and not currently in development.

  2. It must be a new technology, or an innovative modification of an existing technology, which will have benefits to the patient or the NHS when judged against comparators.

  3. The technology must have appropriate UK, CA or CE marks (or equivalent regulatory approval) or be expected to get one within 12 months.

  4. Digital products must have national DTAC or be working towards this within 12 months.

The technology must also be available to the NHS, or have plans to be launched in the NHS.

Our product went from being in 4 hospitals to 15 within 6 months of guidance publication. That was incredible.

Justin HallVice president at NeoTract

Contact us

If you're getting in touch about a scheduled evaluation, please contact [email protected].

For advice on the development of a health technology, you can get support from the NICE Advice service. Operating separately from NICE guidance production, they offer fee-based advice and support around evidence generation or other challenges relating to market access.